Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy monitoring of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated malaria in Mali
PACTR201409000702188Completed
- Sponsor
- WANETAM
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of artemether + lumefantrine and artesunate + amodiaquine in malaria and Malaria (2 arms), sponsored by WANETAM. Primary endpoints: Time to parasite clearance, Adequate clinical and parasitological response and 1 more. Started Oct 2012; status: completed.
02
Drugs
artemether + lumefantrineartesunate + amodiaquine
03
Conditions
malariaMalaria
Beyond the preview
Go deeper on PACTR201409000702188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201409000702188.